相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Incidence of cancer and statin usage-record linkage study
Jari Haukka et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Statins Are Associated With a Reduced Risk of Hepatocellular Carcinoma in a Large Cohort of Patients With Diabetes
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2009)
Pancreatic cancer: A review of the evidence on causation
Andrew R. Hart et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Statins and cancer: A systematic review and meta-analysis
Jaana Kuoppala et al.
EUROPEAN JOURNAL OF CANCER (2008)
Statins reduce the risk of lung cancer in humans* - A large case-control study of US veterans
Vikas Khurana et al.
CHEST (2007)
Statins reduce the risk of pancreatic cancer in humans - A case-control study of half a million veterans
Vikas Khurana et al.
PANCREAS (2007)
Statin use and the risk of 10 cancers
Patricia F. Coogan et al.
EPIDEMIOLOGY (2007)
Statins and risk of cancer: A systematic review and metaanalysis
Danielle R. L. Browning et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Statins and the risk of lung, breast, and colorectal cancer in the elderly
Soko Setoguchi et al.
CIRCULATION (2007)
Epidemiological features of CKD in Taiwan
Hsin-Wei Kuo et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2007)
Trends in the use of antihypertensive drugs by outpatients with diabetes in Taiwan, 1997-2003
Chi-Wen Chiang et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Statins and cancer risk: A literature-based meta-analysis and meta-regression analysis of 35 randomized controlled trials
Stefanos Bonovas et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Statins and cancer risk - A meta-analysis
KM Dale et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Statins and osteoporosis: new role for old drugs
SB Jadhav et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2006)
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
C Baigent et al.
LANCET (2005)
Statins and prostate cancer risk: A case-control study
J Shannon et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2005)
Statins and the risk of colorectal cancer
JN Poynter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Cancer risk among statin users: A population-based cohort study
S Friis et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Statin use and cancer risk in the General Practice Research Database
JA Kaye et al.
BRITISH JOURNAL OF CANCER (2004)
The risk of cancer in users of statins
MR Graaf et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
The association between 3-hydroxy-3-methylglutaryl conenzyme A inhibitor use and breast carcinoma risk among postmenopausal women - A case-control study
DM Boudreau et al.
CANCER (2004)
Lipid-lowering drug use and breast cancer in older women: A prospective study
JA Cauley et al.
JOURNAL OF WOMENS HEALTH (2003)
Comparative effects of lovastatin on mammary and prostate oncogenesis in transgenic mouse models
MA Shibata et al.
CARCINOGENESIS (2003)
3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA
HJ Park et al.
CIRCULATION RESEARCH (2002)
Microarray and biochemical analysis of lovastatin-induced apoptosis of squamous cell carcinomas
J Dimitroulakos et al.
NEOPLASIA (2002)
3-hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/p21 signaling pathway: Implications for diabetic nephropathy
FR Danesh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Statin use and the risk of breast and prostate cancer
PF Coogan et al.
EPIDEMIOLOGY (2002)
HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis
WWL Wong et al.
LEUKEMIA (2002)
Statins have biphasic effects on angiogenesis
M Weis et al.
CIRCULATION (2002)
3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors reduce human pancreatic cancer cell invasion and metastasis
T Kusama et al.
GASTROENTEROLOGY (2002)
3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation
LM Blanco-Colio et al.
ATHEROSCLEROSIS (2002)
Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors
M Takemoto et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and the risk of cancer -: A nested case-control study
L Blais et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
HMG-CoA reductase inhibitors and the risk of fractures
CR Meier et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients
PS Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
分享论文
